We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Sharp & Dohme-Chibret Draws Form 483 for Sterilization Failures
Merck Sharp & Dohme-Chibret Draws Form 483 for Sterilization Failures
FDA investigators handed France-based drug manufacturer Merck Sharp & Dohme-Chibret Laboratories a Form 483 after an inspection revealed sterilization issues and drug batch failures were not reported on time.